News - Legal, Asia-Pacific

Filter

Current filters:

LegalAsia-Pacific

Popular Filters

1 to 25 of 41 results

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

10-02-2014

Swiss pharma major Roche’s Indian subsidiary has sued Bangalore-based Biocon and US generics firm Mylan…

Asia-PacificBioconBiosimilarsCanmabHerceptinHertrazIndiaLegalMylan LaboratoriesOncologyPatentsPharmaceuticalRegulationRoche

Sinopharm executives face corruption probe in China

14-01-2014

China's largest drug distributor, state-owned Sinopharm, has become the most high profile domestic group…

Asia-PacificChinaLegalMarkets & MarketingPharmaceuticalSinopharm

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements

30-12-2013

With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

New legislation for regenerative medicine in Japan

New legislation for regenerative medicine in Japan

22-11-2013

The Japanese legislature (Diet) has approved new legislation targeted at regenerative medicine therapies.…

Asia-PacificBiotechnologyCytori TherapeuticsLegalRegulationResearch

Novartis under investigation for manipulating data in Japanese clinical trials

Novartis under investigation for manipulating data in Japanese clinical trials

27-09-2013

Swiss drug major Novartis has said it regrets the inconvenience caused by its investigator-initiated…

Asia-PacificCardio-vascularLegalNovartisPharmaceuticalRegulationvalsartan

Bayer joins string of drugmakers being investigated in China

16-09-2013

German pharma and crop sciences major Bayer (BAYN: DE) is being investigated in China over a "potential…

Asia-PacificBayerLegalMarkets & MarketingPharmaceutical

Chinese pharma companies now also implicated in bribery allegations

13-09-2013

Chinese drug company Sino Biopharmaceutical is the latest subject of allegations into corruption in the…

Asia-PacificLegalPharmaceutical

GlaxoSmithKline could be considering quitting China, says BBC editor

06-09-2013

For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Chinese police reveal more on GSK China's suspected violations

03-09-2013

The Chinese police have recently revealed more details about suspected economic violations by UK pharma…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Eli Lilly latest to become embroiled in China bribery allegations

23-08-2013

In the ongoing allegations of bribery and corruption by multinational drugmakers in China, US pharma…

Asia-PacificEli LillyLegalMarkets & MarketingPharmaceutical

China starts investigation of alleged bribery by Sanofi

12-08-2013

Following last week's whistleblower allegations that French drug major Sanofi (Euronext: SAN) had paid…

Asia-PacificLegalMarkets & MarketingPharmaceuticalPricingSanofi

Sanofi latest to be implicated Chinese bribery allegations

09-08-2013

In the wake of allegations that several multinational pharma companies have engaged in unlawful marketing…

Asia-PacificLegalLundbeckMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

More details emerge of GSK China bribery allegations

26-07-2013

The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

Investigation on-going as claims GSK staff may have broken Chinese law

22-07-2013

Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…

Asia-PacificGlaxoSmithKlineLegalPharmaceutical

China says GSK probe part of business climate clean-up

17-07-2013

China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates

16-07-2013

Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa

17-04-2013

The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…

Asia-PacificAstraZenecaIressaLegalOncologyPharmaceutical

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Novartis Indian patent hearings close, but no verdict yet

05-12-2012

After more than 12 weeks of hearings in India's Supreme Court, humanitarian aid agency Medecins Sans…

Asia-PacificGlivecLegalNovartisPatentsPharmaceutical

1 to 25 of 41 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top